These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3167647)

  • 1. [Serum theophylline levels in chronic obstructive pulmonary disease patients receiving uniphyllin].
    Chang SC; Perng RP
    Zhonghua Yi Xue Za Zhi (Taipei); 1988 Jan; 41(1):37-42. PubMed ID: 3167647
    [No Abstract]   [Full Text] [Related]  

  • 2. [Optimizing therapy with theophylline preparations in obstructive ventilation disorders. 3. Prediction of theophylline clearance with a simple pharmacokinetic method and comparison of bioavailability of various theophylline retard preparations].
    Ranke C; Schmidt G; Oellerich M; Sybrecht GW
    Prax Klin Pneumol; 1983 Mar; 37(3):99-108. PubMed ID: 6856564
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of a serum concentration-oriented dosage of a theophylline depot preparation in ambulatory patients with chronic obstructive lung disease].
    Harder S; Staib AH; Stauder J
    Prax Klin Pneumol; 1985 Jun; 39(6):193-6. PubMed ID: 4022931
    [No Abstract]   [Full Text] [Related]  

  • 4. [Levels of blood theophylline in patients with acute bronchospasm].
    Martínez MJ; Martínez B; Saucedo R; García Delgado R; García Morillas M; Puche E
    Rev Clin Esp; 1989 May; 184(9):470-2. PubMed ID: 2772324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease.
    Fontana G; Cresci F; Lo Sapio P; Panuccio P
    Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of standard- and sustained-release theophylline tablets in patients with chronic obstructive pulmonary disease.
    Dasta J; Mirtallo JM; Altman M
    Am J Hosp Pharm; 1979 May; 36(5):613-7. PubMed ID: 453214
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum theophylline--a mandatory measurement in the control of therapy?
    Laher MS; O'Regan P; Jackson F; MacCarthy E; Wright E; Counihan TB; Keelan P
    Ir J Med Sci; 1985 May; 154(5):193-7. PubMed ID: 4030279
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of theophyllines in severe chronic obstructive pulmonary disease.
    McNicholas WT; Mulloy E
    Postgrad Med J; 1991; 67 Suppl 4():S30-3. PubMed ID: 1758832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slow release theophylline in patients with airways obstruction with particular reference to the effects of food upon serum levels.
    Thompson PJ; Kemp MW; McAllister WA; Turner-Warwick M
    Br J Dis Chest; 1983 Jul; 77(3):293-8. PubMed ID: 6351891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of various disease states on theophylline plasma levels and on pulmonary function in patients with chronic airway obstruction treated with a sustained release theophylline preparation.
    Dal Negro R; Turco P; Pomari C; Monici-Preti P
    Int J Clin Pharmacol Ther Toxicol; 1987 Jul; 25(7):401-5. PubMed ID: 3305382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of obstructive respiratory disorders using a new theophylline retard preparation].
    Schroers M; Merbach W; Don M
    ZFA (Stuttgart); 1982 Jun; 58(17):974-8. PubMed ID: 7113392
    [No Abstract]   [Full Text] [Related]  

  • 12. [A single dose of theophylline in the evening in chronic obstructive airway disease. Serum concentration and lung function parameter].
    Kaik G
    Fortschr Med; 1984 Nov; 102(43):1120-2. PubMed ID: 6510864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Possibilities for optimizing therapy with theophylline preparations. I. On the pharmacokinetics of theophylline preparations].
    Wiesner B; Sehrt I; Iwainsky H
    Z Erkr Atmungsorgane; 1984; 162(1):3-10. PubMed ID: 6719957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The comparative efficacy of the prolonged-action theophylline preparations Theopek and Euphylong in elderly patients with chronic obstructive lung diseases].
    Salikova VV; Nonikov VE; Belousov IuB
    Ter Arkh; 1993; 65(8):41-4. PubMed ID: 8211801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of theophylline on cortisol plasma concentrations in patients with chronic obstructive pulmonary disease.
    Gimeno F; Steenhuis EJ; Jonkman JH
    Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):139-43. PubMed ID: 2187001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical results obtained from a new controlled release theophylline preparation.
    Nolte D
    Br J Clin Pract Suppl; 1984; 32():14-7. PubMed ID: 6432017
    [No Abstract]   [Full Text] [Related]  

  • 17. Rifampicin-isoniazid and delayed elimination of theophylline: a case report.
    Dal Negro R; Turco P; Trevisan F; De Conti F
    Int J Clin Pharmacol Res; 1988; 8(4):275-7. PubMed ID: 3182118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma theophylline concentrations in patients with chronic obstructive airways disease after administration of a new sustained release theophylline formulation.
    Taylor DR; Kinney CD; McDevitt DG
    Br J Clin Pharmacol; 1982 Apr; 13(4):569-71. PubMed ID: 7066172
    [No Abstract]   [Full Text] [Related]  

  • 19. [Determination of serum theophylline concentration in ambulatory practice].
    Staib AH; Rietbrock N; Neiss A
    Dtsch Med Wochenschr; 1985 Apr; 110(17):680-5. PubMed ID: 3987532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of parenteral aminophylline in patients taking slow release theophylline preparations: an observation of clinical practice.
    Arbab OA; Wiggins J; Ayres JG; Stableforth DE
    Br J Dis Chest; 1985 Apr; 79(2):161-71. PubMed ID: 3986120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.